Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.
about
Gene therapy for peripheral arterial diseaseRegenerative therapies for diabetic microangiopathyInflammation in Chronic WoundsVEGF gene therapy: therapeutic angiogenesis in the clinic and beyondMechanisms of Amplified Arteriogenesis in Collateral Artery Segments Exposed to Reversed Flow Direction.Computational Network Model Prediction of Hemodynamic Alterations Due to Arteriolar Rarefaction and Estimation of Skeletal Muscle Perfusion in Peripheral Arterial Disease.Systems biology of pro-angiogenic therapies targeting the VEGF systemTargets and delivery methods for therapeutic angiogenesis in peripheral artery diseaseTherapeutic angiogenesis for critical limb ischaemia.Myoglobin overexpression inhibits reperfusion in the ischemic mouse hindlimb through impaired angiogenesis but not arteriogenesis.Critical limb ischemia: current approach and future directions.Intra-arterial transplantation of adult bone marrow cells restores blood flow and regenerates skeletal muscle in ischemic limbs.Vascular endothelial growth factor signaling in hypoxia and inflammation.Critical limb ischemiaGene therapy in the treatment of peripheral arterial disease.Present and new techniques and devices in the treatment of DFU: a critical review of evidence.A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes.TLR2 and TLR4 mediate differential responses to limb ischemia through MyD88-dependent and independent pathwaysPharmacology in peripheral arterial disease: what the interventional radiologist needs to know.Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer.Characterization of mesenchymal stem cells of "no-options" patients with critical limb ischemia treated by autologous bone marrow mononuclear cellsSecretoneurin gene therapy improves blood flow in an ischemia model in type 1 diabetic mice by enhancing therapeutic neovascularization.Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia.Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent.Cardiovascular gene therapy: current status and therapeutic potential.New vectors and strategies for cardiovascular gene therapy.Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial diseaseImbalance of angiogenesis in diabetic complications: the mechanisms.Clinical improvement after treatment with VEGF(165) in patients with severe chronic lower limb ischaemia.Plasmid-based gene therapy of diabetes mellitus.Clinical application of growth factors and cytokines in wound healingEffects of survivin on angiogenesis in vivo and in vitro.Modulating the vascular response to limb ischemia: angiogenic and cell therapies.From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-T.Progress and prospects: gene therapy clinical trials (part 1).Controlled release systems of angiogenic growth factors for cardiovascular diseases.PKCδ impaired vessel formation and angiogenic factor expression in diabetic ischemic limbs.Therapeutic angiogenesis in critical limb ischemia.Biological approaches to ischemic tissue repair: gene- and cell-based strategies.Gene and stem cell therapy in peripheral arterial occlusive disease.
P2860
Q24186712-8B99B663-C602-4A8C-8739-A6F11EE42E83Q27027852-4128B118-0015-4E8D-A549-27FEE54C4060Q28075962-C2C5840F-EA6E-46A4-AF0A-CBEB61ABD832Q28260984-E08EEFC8-C876-4ED8-B9C4-32251F6D72C5Q30278752-639FCC58-2F56-4450-AF89-8522A7C36DDCQ30300196-0B78BFB7-B6ED-49F4-811B-C75A97571325Q30430112-197B44EC-3660-4639-B449-2A336E5EAB60Q30449821-C9848F79-25A0-4B05-A8D3-02DA3DEE6AFFQ30456666-D2B57432-6CCE-483B-8649-667EF0801500Q30457043-66FD3A29-FB95-4250-8770-7F485E37D699Q30458139-1A5D1720-E97A-465E-A21B-7C9F92C30CB1Q33486302-4D01943A-91FA-463E-9730-4A60B4110A85Q33721685-97031BC7-F2C7-420B-81CB-BDEFFFAE38BEQ33814176-3DCC338E-EAF0-4407-BED8-ECA4F20922DAQ34070287-DEFF09C6-BB0E-470E-A19E-00A6F8F89B62Q34137019-CBD1D672-2043-4B05-A83B-C5C9888016BCQ34137026-F510E3AC-E0AA-4B5D-8FDF-46B4222F0FEFQ34500561-A170B529-E805-4C27-BFDB-E460227139EAQ34513880-3AEBC482-ABE3-422A-802C-D5E895918FF5Q34943604-A8A5639B-FE37-4C1F-B0ED-38707CFAAC2EQ34998811-A6135B90-D386-42EF-9110-F8670F5FF292Q35004854-3846C791-A9FA-4837-A6E0-356F69CAE6C5Q35582797-118EA2ED-F5EF-4573-91A6-3799CB8C9EA7Q35618768-3EF154AB-40A2-420E-B808-155C78E79A64Q35995220-337936D4-09D2-4171-BEAC-C55FDC9D7692Q36174173-F0D716DB-EE45-4E2A-B4EC-62443CF3184AQ36274594-CFB4F0A6-BF49-4F6C-870C-8BEE56750912Q36489031-7FCE0267-D2C8-4D7F-B18B-6337D74F424EQ36513597-7B7E0238-9E03-48EC-A344-6ECBAA1D123AQ36704473-BD4105FB-155D-4A19-9425-5D0AD9802B78Q36742273-3EA5F0D7-6A77-4779-B4B6-34C674622A03Q36841092-AE0A3EA2-25CB-46AD-A4BE-6278D889D0BAQ36908997-17D344BD-42B4-479C-B0B4-7A8FD2102A56Q36923569-E78A2B17-2A1E-4730-A349-427B2168BABDQ36957474-BCA63BF8-C0BD-4CFF-BCFB-920B30D32FE1Q36985904-2E01297C-F432-4733-9644-5CBFDD38C616Q37031000-35A04194-7CC4-429F-8666-8B9BE04A9541Q37142832-E667BA1D-645B-4032-A46F-D34B844B0CA2Q37176436-2E5C96DA-F37F-4338-A7FE-68004184ABBCQ37204529-6CDAA882-ADC7-4508-B0F6-D5E6BD177EF9
P2860
Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Treatment with intramuscular v ...... double-blind randomized trial.
@en
Treatment with intramuscular v ...... double-blind randomized trial.
@nl
type
label
Treatment with intramuscular v ...... double-blind randomized trial.
@en
Treatment with intramuscular v ...... double-blind randomized trial.
@nl
prefLabel
Treatment with intramuscular v ...... double-blind randomized trial.
@en
Treatment with intramuscular v ...... double-blind randomized trial.
@nl
P2093
P921
P356
P1433
P1476
Treatment with intramuscular v ...... double-blind randomized trial
@en
P2093
G A P Hospers
J J A M van den Dungen
J M M Hooymans
N H Mulder
R O B Gans
R P F Dullaart
V van Weel
W J Sluiter
P304
P356
10.1089/HUM.2006.17.683
P50
P577
2006-06-01T00:00:00Z